|
|
Blood, 15 August 2006, Vol. 108, No. 4, pp. 1291-1297.
Prepublished online as a Blood First Edition Paper on April 20, 2006; DOI 10.1182/blood-2006-02-003996.
Previous Article | Next Article 
Submitted February 15, 2006
Accepted April 4, 2006
High donor Foxp3-positive regulatory T-cell (TREG) content is associated with a low risk of GVHD following HLA-matched allogeneic stem cell transplantation (SCT)
Katayoun Rezvani*, Stephan Mielke, Mojgan Ahmadzadeh, Yasemin Kilical, Bipin N Savani, Josette Zeilah, Keyvan Keyvanfar, Aldemar Montero, Nancy Hensel, Roger Kurlander, and A John Barrett
Stem Cell Allogeneic Transplantation Section,Hematology Branch,National Heart Lung & Blood Institute
Department of Surgery, National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD
Department of Laboratory Medicine, National Institutes of Health (NIH), Bethesda, MD, USA
* Corresponding author; email: rezvanik{at}nhlbi.nih.gov.
Regulatory T-cells (TREGs)that constitutively express Foxp3 are instrumental to the maintenance of tolerance and may suppress graft-versus-host disease (GVHD) in man. To determine whether regulatory T-cells in allogeneic stem cell transplants (SCT) ameliorate GVHD after transplantation we quantitated the coexpression of Foxp3 on CD4+ T-cells in 32 donor SCT infused into HLA-matched siblings and examined GVHD incidence in respective recipients. High CD4+Foxp3+ T-cell count in the donor was associated with an reduced risk of GVHD. We monitored TREG during immune reconstitution in 21 patients with leukemia undergoing a T-cell depleted allogeneic SCT. Early post-SCT, there was a significant expansion in the CD4+Foxp3+ T-cell compartment. A low CD4+Foxp3+ T-cell count early post-SCT (day 30) was associated with an increased risk of GVHD and the ratio of CD4+Foxp3+ T-cells to CD4+CD25+Foxp3-T-cells was significantly reduced in patients with GVHD suggesting diminished control of effector T-cells. Our findings suggest that graft TREG content may predict for risk of GVHD post-SCT. Determining the TREG levels in the donor and manipulating TREGs early after transplantation may provide a new approach to controlling GVHD.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Article in Blood Online:
-
Donor Foxp3-positive T cells: the missing link
- Allan D. Hess
Blood 2006 108: 1121-1122.
[Full Text]
This article has been cited by other articles:

|
 |

|
 |
 
J. K. Davies, L. M. Nadler, and E. C. Guinan
Expansion of Allospecific Regulatory T Cells After Anergized, Mismatched Bone Marrow Transplantation
Science Translational Medicine,
October 7, 2009;
1(1):
1ra3 - 1ra3.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Xie, M. Wu, R. Song, J. Ma, Y. Shi, W. Qin, and Y. Jin
A glucocorticoid amplifies IL-2-induced selective expansion of CD4+CD25+FOXP3+ regulatory T cells in vivo and suppresses graft-versus-host disease after allogeneic lymphocyte transplantation
Acta Biochim Biophys Sin,
September 1, 2009;
41(9):
781 - 791.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Matthews, Z. Lim, B. Afzali, L. Pearce, A. Abdallah, S. Kordasti, A. Pagliuca, G. Lombardi, J. A. Madrigal, G. J. Mufti, et al.
Imbalance of effector and regulatory CD4 T cells is associated with graft-versus-host disease after hematopoietic stem cell transplantation using a reduced intensity conditioning regimen and alemtuzumab
Haematologica,
July 1, 2009;
94(7):
956 - 966.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Blanco, J. A. Perez-Simon, L. I. Sanchez-Abarca, T. Caballero-Velazquez, S. Gutierrez-Cossio, P. Hernandez-Campo, M. Diez-Campelo, C. Herrero-Sanchez, C. Rodriguez-Serrano, C. Santamaria, et al.
Treatment with bortezomib of human CD4+ T cells preserves natural regulatory T cells and allows the emergence of a distinct suppressor T-cell population
Haematologica,
July 1, 2009;
94(7):
975 - 983.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Bohana-Kashtan, S. Morisot, R. Hildreth, C. Brayton, H. I. Levitsky, and C. I. Civin
Selective Reduction of Graft-versus-Host Disease-Mediating Human T Cells by Ex Vivo Treatment with Soluble Fas Ligand
J. Immunol.,
July 1, 2009;
183(1):
696 - 705.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ahmadzadeh, A. Felipe-Silva, B. Heemskerk, D. J. Powell Jr, J. R. Wunderlich, M. J. Merino, and S. A. Rosenberg
FOXP3 expression accurately defines the population of intratumoral regulatory T cells that selectively accumulate in metastatic melanoma lesions
Blood,
December 15, 2008;
112(13):
4953 - 4960.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Gatza, C. E. Rogers, S. G. Clouthier, K. P. Lowler, I. Tawara, C. Liu, P. Reddy, and J. L. M. Ferrara
Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells
Blood,
August 15, 2008;
112(4):
1515 - 1521.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Mielke, R. Nunes, K. Rezvani, V. S. Fellowes, A. Venne, S. R. Solomon, Y. Fan, E. Gostick, D. A. Price, C. Scotto, et al.
A clinical-scale selective allodepletion approach for the treatment of HLA-mismatched and matched donor-recipient pairs using expanded T lymphocytes as antigen-presenting cells and a TH9402-based photodepletion technique
Blood,
April 15, 2008;
111(8):
4392 - 4402.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Feng, S. Kajigaya, E. E. Solomou, K. Keyvanfar, X. Xu, N. Raghavachari, P. J. Munson, T. M. Herndon, J. Chen, and N. S. Young
Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitro
Blood,
April 1, 2008;
111(7):
3675 - 3683.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Atanackovic, Y. Cao, T. Luetkens, J. Panse, C. Faltz, J. Arfsten, K. Bartels, C. Wolschke, T. Eiermann, A. R. Zander, et al.
CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation
Haematologica,
March 1, 2008;
93(3):
423 - 430.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Barrett
Leukemia Vaccines to Boost the Graft-versus-Leukemia Effect after Allogeneic Stem Cell Transplantation
ASCO Educational Book,
January 1, 2008;
2008(1):
330 - 333.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. E. Solomou, K. Rezvani, S. Mielke, D. Malide, K. Keyvanfar, V. Visconte, S. Kajigaya, A. J. Barrett, and N. S. Young
Deficient CD4+ CD25+ FOXP3+ T regulatory cells in acquired aplastic anemia
Blood,
September 1, 2007;
110(5):
1603 - 1606.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Mielke, K. Rezvani, B. N. Savani, R. Nunes, A. S. M. Yong, J. Schindler, R. Kurlander, V. Ghetie, E. J. Read, S. R. Solomon, et al.
Reconstitution of FOXP3+ regulatory T cells (Tregs) after CD25-depleted allotransplantion in elderly patients and association with acute graft-versus-host disease
Blood,
September 1, 2007;
110(5):
1689 - 1697.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Pabst, H. Schirutschke, G. Ehninger, M. Bornhauser, and U. Platzbecker
The Graft Content of Donor T Cells Expressing {gamma}{delta}TCR+ and CD4+foxp3+ Predicts the Risk of Acute Graft versus Host Disease after Transplantation of Allogeneic Peripheral Blood Stem Cells from Unrelated Donors
Clin. Cancer Res.,
May 15, 2007;
13(10):
2916 - 2922.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Chen, F. M. Ellison, M. A. Eckhaus, A. L. Smith, K. Keyvanfar, R. T. Calado, and N. S. Young
Minor Antigen H60-Mediated Aplastic Anemia Is Ameliorated by Immunosuppression and the Infusion of Regulatory T Cells
J. Immunol.,
April 1, 2007;
178(7):
4159 - 4168.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|